Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Pharmaceutical Software market size was valued at USD 2605.3 million in 2022 and is forecast to a readjusted size of USD 5313.7 million by 2029 with a CAGR of 10.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Pharmaceutical software refers to an umbrella term for a variety of technology solutions used by manufacturers, raw material suppliers, wholesalers, including drug stores and healthcare providers.
This report is a detailed and comprehensive analysis for global Pharmaceutical Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
The Primary Objectives in This Report Are:
This report profiles key players in the global Pharmaceutical Software market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Tata Consultancy Services, Cognizant, Capgemini, Microsoft and Oracle, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Pharmaceutical Software market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Market segment by Application
Market segment by players, this report covers
Market segment by regions, regional analysis covers
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical Software, with revenue, gross margin and global market share of Pharmaceutical Software from 2018 to 2023.
Chapter 3, the Pharmaceutical Software competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmaceutical Software market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Software.
Chapter 13, to describe Pharmaceutical Software research findings and conclusion.
Index
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical Software
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmaceutical Software by Type
1.3.1 Overview: Global Pharmaceutical Software Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Pharmaceutical Software Consumption Value Market Share by Type in 2022
1.3.3 Software
1.3.4 Services
1.4 Global Pharmaceutical Software Market by Application
1.4.1 Overview: Global Pharmaceutical Software Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Pharmaceutical Software Market Size & Forecast
1.6 Global Pharmaceutical Software Market Size and Forecast by Region
1.6.1 Global Pharmaceutical Software Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Pharmaceutical Software Market Size by Region, (2018-2029)
1.6.3 North America Pharmaceutical Software Market Size and Prospect (2018-2029)
1.6.4 Europe Pharmaceutical Software Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Pharmaceutical Software Market Size and Prospect (2018-2029)
1.6.6 South America Pharmaceutical Software Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Pharmaceutical Software Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Tata Consultancy Services
2.1.1 Tata Consultancy Services Details
2.1.2 Tata Consultancy Services Major Business
2.1.3 Tata Consultancy Services Pharmaceutical Software Product and Solutions
2.1.4 Tata Consultancy Services Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Tata Consultancy Services Recent Developments and Future Plans
2.2 Cognizant
2.2.1 Cognizant Details
2.2.2 Cognizant Major Business
2.2.3 Cognizant Pharmaceutical Software Product and Solutions
2.2.4 Cognizant Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Cognizant Recent Developments and Future Plans
2.3 Capgemini
2.3.1 Capgemini Details
2.3.2 Capgemini Major Business
2.3.3 Capgemini Pharmaceutical Software Product and Solutions
2.3.4 Capgemini Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Capgemini Recent Developments and Future Plans
2.4 Microsoft
2.4.1 Microsoft Details
2.4.2 Microsoft Major Business
2.4.3 Microsoft Pharmaceutical Software Product and Solutions
2.4.4 Microsoft Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Microsoft Recent Developments and Future Plans
2.5 Oracle
2.5.1 Oracle Details
2.5.2 Oracle Major Business
2.5.3 Oracle Pharmaceutical Software Product and Solutions
2.5.4 Oracle Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Oracle Recent Developments and Future Plans
2.6 Tech Mahindra
2.6.1 Tech Mahindra Details
2.6.2 Tech Mahindra Major Business
2.6.3 Tech Mahindra Pharmaceutical Software Product and Solutions
2.6.4 Tech Mahindra Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Tech Mahindra Recent Developments and Future Plans
2.7 Apple
2.7.1 Apple Details
2.7.2 Apple Major Business
2.7.3 Apple Pharmaceutical Software Product and Solutions
2.7.4 Apple Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Apple Recent Developments and Future Plans
2.8 Wipro
2.8.1 Wipro Details
2.8.2 Wipro Major Business
2.8.3 Wipro Pharmaceutical Software Product and Solutions
2.8.4 Wipro Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Wipro Recent Developments and Future Plans
2.9 Infosys
2.9.1 Infosys Details
2.9.2 Infosys Major Business
2.9.3 Infosys Pharmaceutical Software Product and Solutions
2.9.4 Infosys Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Infosys Recent Developments and Future Plans
2.10 IBM
2.10.1 IBM Details
2.10.2 IBM Major Business
2.10.3 IBM Pharmaceutical Software Product and Solutions
2.10.4 IBM Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 IBM Recent Developments and Future Plans
2.11 SAP
2.11.1 SAP Details
2.11.2 SAP Major Business
2.11.3 SAP Pharmaceutical Software Product and Solutions
2.11.4 SAP Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 SAP Recent Developments and Future Plans
2.12 BatchMaster Software
2.12.1 BatchMaster Software Details
2.12.2 BatchMaster Software Major Business
2.12.3 BatchMaster Software Pharmaceutical Software Product and Solutions
2.12.4 BatchMaster Software Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 BatchMaster Software Recent Developments and Future Plans
2.13 Columbus Manufacturing
2.13.1 Columbus Manufacturing Details
2.13.2 Columbus Manufacturing Major Business
2.13.3 Columbus Manufacturing Pharmaceutical Software Product and Solutions
2.13.4 Columbus Manufacturing Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Columbus Manufacturing Recent Developments and Future Plans
2.14 Aquilon Software
2.14.1 Aquilon Software Details
2.14.2 Aquilon Software Major Business
2.14.3 Aquilon Software Pharmaceutical Software Product and Solutions
2.14.4 Aquilon Software Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Aquilon Software Recent Developments and Future Plans
2.15 CompuTec S.A. (ProcessForce)
2.15.1 CompuTec S.A. (ProcessForce) Details
2.15.2 CompuTec S.A. (ProcessForce) Major Business
2.15.3 CompuTec S.A. (ProcessForce) Pharmaceutical Software Product and Solutions
2.15.4 CompuTec S.A. (ProcessForce) Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 CompuTec S.A. (ProcessForce) Recent Developments and Future Plans
2.16 Datacor Chempax
2.16.1 Datacor Chempax Details
2.16.2 Datacor Chempax Major Business
2.16.3 Datacor Chempax Pharmaceutical Software Product and Solutions
2.16.4 Datacor Chempax Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Datacor Chempax Recent Developments and Future Plans
2.17 DESKERA
2.17.1 DESKERA Details
2.17.2 DESKERA Major Business
2.17.3 DESKERA Pharmaceutical Software Product and Solutions
2.17.4 DESKERA Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 DESKERA Recent Developments and Future Plans
2.18 ERPAG
2.18.1 ERPAG Details
2.18.2 ERPAG Major Business
2.18.3 ERPAG Pharmaceutical Software Product and Solutions
2.18.4 ERPAG Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 ERPAG Recent Developments and Future Plans
2.19 Fishbowl
2.19.1 Fishbowl Details
2.19.2 Fishbowl Major Business
2.19.3 Fishbowl Pharmaceutical Software Product and Solutions
2.19.4 Fishbowl Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Fishbowl Recent Developments and Future Plans
2.20 Intellect
2.20.1 Intellect Details
2.20.2 Intellect Major Business
2.20.3 Intellect Pharmaceutical Software Product and Solutions
2.20.4 Intellect Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Intellect Recent Developments and Future Plans
2.21 SAGE GROUP plc
2.21.1 SAGE GROUP plc Details
2.21.2 SAGE GROUP plc Major Business
2.21.3 SAGE GROUP plc Pharmaceutical Software Product and Solutions
2.21.4 SAGE GROUP plc Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 SAGE GROUP plc Recent Developments and Future Plans
2.22 VAI - Vormittag Associates, Inc.
2.22.1 VAI - Vormittag Associates, Inc. Details
2.22.2 VAI - Vormittag Associates, Inc. Major Business
2.22.3 VAI - Vormittag Associates, Inc. Pharmaceutical Software Product and Solutions
2.22.4 VAI - Vormittag Associates, Inc. Pharmaceutical Software Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 VAI - Vormittag Associates, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pharmaceutical Software Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Pharmaceutical Software by Company Revenue
3.2.2 Top 3 Pharmaceutical Software Players Market Share in 2022
3.2.3 Top 6 Pharmaceutical Software Players Market Share in 2022
3.3 Pharmaceutical Software Market: Overall Company Footprint Analysis
3.3.1 Pharmaceutical Software Market: Region Footprint
3.3.2 Pharmaceutical Software Market: Company Product Type Footprint
3.3.3 Pharmaceutical Software Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Pharmaceutical Software Consumption Value and Market Share by Type (2018-2023)
4.2 Global Pharmaceutical Software Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Pharmaceutical Software Consumption Value Market Share by Application (2018-2023)
5.2 Global Pharmaceutical Software Market Forecast by Application (2024-2029)
6 North America
6.1 North America Pharmaceutical Software Consumption Value by Type (2018-2029)
6.2 North America Pharmaceutical Software Consumption Value by Application (2018-2029)
6.3 North America Pharmaceutical Software Market Size by Country
6.3.1 North America Pharmaceutical Software Consumption Value by Country (2018-2029)
6.3.2 United States Pharmaceutical Software Market Size and Forecast (2018-2029)
6.3.3 Canada Pharmaceutical Software Market Size and Forecast (2018-2029)
6.3.4 Mexico Pharmaceutical Software Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Pharmaceutical Software Consumption Value by Type (2018-2029)
7.2 Europe Pharmaceutical Software Consumption Value by Application (2018-2029)
7.3 Europe Pharmaceutical Software Market Size by Country
7.3.1 Europe Pharmaceutical Software Consumption Value by Country (2018-2029)
7.3.2 Germany Pharmaceutical Software Market Size and Forecast (2018-2029)
7.3.3 France Pharmaceutical Software Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Pharmaceutical Software Market Size and Forecast (2018-2029)
7.3.5 Russia Pharmaceutical Software Market Size and Forecast (2018-2029)
7.3.6 Italy Pharmaceutical Software Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Software Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Pharmaceutical Software Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Pharmaceutical Software Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical Software Consumption Value by Region (2018-2029)
8.3.2 China Pharmaceutical Software Market Size and Forecast (2018-2029)
8.3.3 Japan Pharmaceutical Software Market Size and Forecast (2018-2029)
8.3.4 South Korea Pharmaceutical Software Market Size and Forecast (2018-2029)
8.3.5 India Pharmaceutical Software Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Pharmaceutical Software Market Size and Forecast (2018-2029)
8.3.7 Australia Pharmaceutical Software Market Size and Forecast (2018-2029)
9 South America
9.1 South America Pharmaceutical Software Consumption Value by Type (2018-2029)
9.2 South America Pharmaceutical Software Consumption Value by Application (2018-2029)
9.3 South America Pharmaceutical Software Market Size by Country
9.3.1 South America Pharmaceutical Software Consumption Value by Country (2018-2029)
9.3.2 Brazil Pharmaceutical Software Market Size and Forecast (2018-2029)
9.3.3 Argentina Pharmaceutical Software Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Software Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Pharmaceutical Software Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Pharmaceutical Software Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical Software Consumption Value by Country (2018-2029)
10.3.2 Turkey Pharmaceutical Software Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Pharmaceutical Software Market Size and Forecast (2018-2029)
10.3.4 UAE Pharmaceutical Software Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Pharmaceutical Software Market Drivers
11.2 Pharmaceutical Software Market Restraints
11.3 Pharmaceutical Software Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Pharmaceutical Software Industry Chain
12.2 Pharmaceutical Software Upstream Analysis
12.3 Pharmaceutical Software Midstream Analysis
12.4 Pharmaceutical Software Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch